Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production
Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd.
Being well prepared for your job application
In 2021, Sartorius hired around 4,000 people worldwide. The recruiting team has scanned through tens of thousands of applications to identify the candidates they would invite for interviews and consider for a job. But what is it that they look for? What gets their attention?
Havant: A state-of-the-art facility for downstream processing equipment
Sartorius is expanding its presence in the UK with a new 58,000-square-foot manufacturing facility in Havant, Hampshire.
ReNeuron to use Cellmate automated cell culture for stem cell-based stroke therapy
ReNeuron to use Cellmate Automated Cell Culture for Stem Cell-based Stroke Therapy To Accelerate Production at New Advanced Therapy Medicinal Products Manufacturing Facility in Wales
New ambr® bioreactor systems enhanced with software for Design of Experiments (DoE)
Enables robust, flexible bioprocess development in single-use bioreactors
New Collaboration between TAP Biosystems and UCL
To develop biomimetic 3D cancer models for use in drug discovery
TAP Biosystems collaborates with OU to develop biomimetic 3D CNS models
TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications,is pleased to announce that it is collaborating with scientists at The Open University (OU), in Milton Keynes, UK to produce robust 3D human central nervous system (CNS) tissue models for use in drug discovery and pre-clinical testing.